The Hybrid Trial Participant Journey Blueprint

Digital Does Not Automatically Mean Connected.

A hybrid trial may include:

digital recruitment,
remote pre-screening,
eConsent,
telemedicine,
eCOA/ePRO,
wearables,
home health,
remote monitoring,
EDC,
CTMS,
payment platforms,
patient apps.

Each component can work perfectly.

The participant journey can still break.

Why?

Because the highest-friction moments often happen between systems.

For example:

A patient is matched but nobody owns outreach.

A patient consents, but another system does not know the permission state.

A telehealth visit is completed, but the milestone does not automatically trigger reimbursement.

A wearable generates data, but operational teams cannot easily connect it to participant status.

A participant withdraws, but downstream systems do not react consistently.

The real DCT architecture is not the list of tools.

It is the transitions between participant states.

5. The Core Blueprint

The hybrid participant journey should be designed around eight states:

1. Discover

Potential participant identified. 2. Engage

Patient contacted through an appropriate channel.

3. Understand

Patient receives clear study information and decides whether to continue.

4. Authorize

Consent and relevant permissions are captured.

5. Verify

Eligibility evidence and required clinical data are confirmed.

6. Participate

Patient completes remote and/or site-based trial activities.

7. Recognize

Study milestone completion is verified.

8. Compensate

Participant reimbursement or payment is triggered and tracked.

The goal is not to move every function into one system.

The goal is to make every state transition clear, measurable, and governed.

6. Blueprint Stage 1 — Discover

Objective Identify plausible participants before burdening site coordinators.

Questions

Where do candidates come from?

site databases,
EHRs,
referral partners,
provider networks,
patient communities,
digital recruitment,
registries,
data partnerships.

Can the team distinguish:

potentially eligible

from

simply available?

Strong workflow

Candidate signals are structured enough to support early prioritization.

Weak workflow

Coordinators manually inspect large numbers of records or leads before knowing whether a patient is plausible.

Blueprint output

Candidate Discovery Map

7. Blueprint Stage 2 — Engage

Objective Move from patient discovery to compliant, timely contact.

Questions

Who is allowed to contact the patient?

Who owns the first touch?

Can outreach be provider-mediated where needed?

What happens when the patient comes from an external network?

Can contact status be seen across the workflow?

Strong workflow

Every candidate has a defined outreach owner and next action.

Weak workflow

Candidates are identified but stall between data source, provider, recruitment vendor and site.

Blueprint output

Recontact Ownership Map

8. Blueprint Stage 3 — Understand

Objective

Help the patient understand what participation actually involves.

The study should not only communicate:

protocol purpose,
procedures,
risks.

It should also make the operating experience clear:
remote tasks,
site visits,
travel,
devices,
data sharing,
time commitment,
reimbursement,
payment timing.

Strong workflow

The patient understands both the clinical and practical implications before progressing.

Weak workflow

Operational burden only becomes clear after consent.

Blueprint output

Participant Expectation Map

9. Blueprint Stage 4 — Authorize

Objective

Capture consent and permissions in a way that supports downstream action.

Questions

What did the participant agree to?

What data can be accessed?

For what purpose?

For how long?

Can consent change? Can permission be revoked?

Do downstream systems know current permission status?

Strong workflow

Consent is operationally usable.

Weak workflow

A signed document exists, but staff still need manual interpretation before accessing data or proceeding.

Blueprint output

Consent-to-Permission Map

10. Blueprint Stage 5 — Verify

Objective

Confirm eligibility and required evidence before unnecessary participant effort.

Potential evidence

Labs

Medication history

Diagnoses

Imaging

Pathology

Biomarkers

Treatment history

Specialist notes Longitudinal observations

Questions

Where does each piece of evidence live?

Can it be accessed remotely?

Is it structured?

Does the patient need to retrieve it?

Does a site coordinator need to call another provider?

Can missing evidence be identified before screening?

Strong workflow

The study knows what evidence is available and what is missing before formal screening.

Weak workflow

Patients arrive for screening before the team knows whether key evidence exists.

Blueprint output

Eligibility Evidence Map

11. Blueprint Stage 6 — Participate

Objective

Create one coherent experience across remote and physical trial activities.

Participation may include:

video visits,
clinic visits,
home health,
ePRO/eCOA,
wearables,
diaries,
medication reminders,
sample collection,
imaging,
device interactions.

Questions

Does the participant know what is next?

Does the site know what the participant has completed?

Do remote and site-based activities share status?

Can missed tasks generate meaningful follow-up?

Are duplicate reminders being sent from different systems?

Strong workflow

Remote and physical activities behave like one journey.

Weak workflow

The participant experiences several disconnected trial products.

Blueprint output

Hybrid Participation Journey

12. Blueprint Stage 7 — Recognize

Objective

Turn completed activities into trusted operational events.

For example:
visit completed,
questionnaire submitted,
telehealth appointment completed,
device milestone reached,
required data delivered,
travel event approved.

Questions

Which system proves completion?

Who verifies it?

Does another person need to re-enter the event?

Can the event trigger the next workflow automatically?

Strong workflow

The milestone is machine-readable or operationally visible enough to drive downstream activity.

Weak workflow

Staff manually reconcile EDC, CTMS, ePRO, email and payment records.

Blueprint output

Milestone Verification Map

13. Blueprint Stage 8 — Compensate

Objective

Make participant reimbursement or payment feel like part of the trial experience, not an afterthought.

Map the journey Milestone completed

→ Eligibility confirmed

→ Payment approved

→ Exception resolved

→ Funds issued

→ Participant notified

Questions

Can the milestone trigger payment workflow?

How much manual review is required?

Can the participant see status?

Can site staff see status?

Are travel costs prepaid or reimbursed?

Strong workflow

Payment follows the verified participant milestone with minimal avoidable delay.

Weak workflow

The payment platform is fast, but authorization is slow.

Blueprint output

Milestone-to-Payment Map

14. The 12 Hybrid Trial Handoffs to Inspect

The participant experience is most likely to break at these transitions: 1.

Candidate data → recruitment workflow

2. Recruitment workflow → site/provider outreach

3. Outreach → pre-screen

4. Pre-screen → eConsent

5. Consent → permissioned data access

6. Data access → eligibility verification

7. Eligibility → scheduling

8. Remote activity → CTMS/EDC status

9. Device/ePRO event → operational follow-up

10. Visit completion → milestone verification

11.

Milestone verification → payment approval 12.

Withdrawal/change in consent → downstream systems

If those twelve transitions work, the technology stack starts behaving like a participant journey.

15. The Hybrid Trial Control Plane

What should remain in existing systems?

EDC

Clinical trial data capture.

CTMS

Study and site operational management.

eConsent

Consent execution and documentation.

ePRO/eCOA

Participant-reported outcomes.

Payment rail

Movement of participant funds.

EHR / source systems

Clinical source data.

What needs orchestration across them? Participant identity

Consent/permission state

Workflow state

Eligibility readiness

Milestone events

Access governance

Payment triggers

Cross-system audit history

This is the layer MinervaLedger is eventually positioned around.

But the child magnet should teach the architecture before it introduces the product.

16. What to Centralize vs What Not to Centralize

Centralize visibility of:

participant journey state,
current consent status,
permission status,
missing eligibility evidence,
completed milestones,
payout status.

Do not unnecessarily centralize:

full EDC functionality,
CTMS functionality,
every source clinical record,
specialist vendor functionality. The goal is not one giant replacement system.

The goal is one understandable participant journey.

17. The Hybrid Journey Health Check

For every participant stage, ask four questions.

1. Is the owner clear?

Who moves the patient forward?

2. Is the state visible?

Can the relevant team see where the patient is?

3. Is the permission clear?

Can the participant's data be used for the next action?

4. Can the next event trigger automatically?

Or does someone need to manually reconcile systems?

If any transition fails two or more of these checks, it deserves attention.

18. What to Measure

A hybrid-trial initiative should not only measure software adoption.

Track operating metrics such as:

candidate-to-contact time,
likely-eligible-to-consent time,
consent-to-screening time,
missing-evidence rate,
screen-failure rate,
participant task completion,
participant support tickets,
coordinator hours per participant,
milestone-to-payment time,
dropout rate,
cost per randomized patient.

These connect digital strategy to trial economics.

Map the Journey Before You Add Another Digital Tool.

Use the Hybrid Trial Participant Journey Blueprint with your Clinical Operations, DCT, Clinical Technology and Patient Experience teams.

Download includes

8-stage participant journey blueprint
12 critical handoffs
system ownership map
consent/permission worksheet
milestone verification worksheet
payment workflow map
hybrid journey health check

CTA Button

Download the Hybrid Trial Blueprint

Fields

First name Work email Company Microcopy

No phone number required. No sales call required.

COVER